In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin

Santoro, M, Maetzler, W, Stathakos, P, Martin, H L, Hobert, M A, Rattray, T W, Gasser, T, Forrester, J V, Berg, D, Tracey, K J, Riedel, G & Teismann, P 2016, 'In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin', Neurobiology of Disease, vol. 91, pp. 59-68. https://doi.org/10.1016/j.nbd.2016.02.018